Skip to main content

Zevra Therapeutics, Inc 10-K for FY2023

Zevra Therapeutics, Inc. (ZVRA)

10-K 2024-04-01 For: 2023-12-31
View Original
Added on April 10, 2026

About this 10-K

Zevra Therapeutics, Inc filed this 10-K on April 1, 2024, covering the fiscal year ended December 31, 2023 (FY2023).

Headline figures

Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$27.46M
up 170.3% from $10.16M a year earlier
Net loss
$46.05M
compared with a net loss of $26.77M a year earlier